About Daniel Schmitt
Daniel Schmitt is a president, CEO and director at Actuate Therapeutics.
Daniel Schmitt reports to the SEC as a director or officer of 2 public companies, including Immtech Pharmaceuticals (IMM).
Daniel Schmitt first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Schmitt in the role, so the role may have started earlier or lasted longer.
II
Immtech Pharmaceuticals, Inc.
VP, Licensing & Comm Dev
2006 · Public company (IMM)
Key Colleagues at Startups
The people Daniel Schmitt works with at each company, as listed on that company's latest Form D.
Actuate Therapeutics, Inc. · Form D, Jul 7, 2025
TT
Todd Thomson
Director
PL
Paul Lytle
Chief Financial Officer
RS
Roger Sawhney
Director
AM
Andrew Mazar
Executive officer
AR
Amy Ronneberg
Director
DZ
Daniel Zabrowski
Director
JK
Jason Keyes
Director
AF
Aaron Fletcher
Director